New hope for High-Risk moms: can a simple shot stop a dangerous pregnancy complication?
NCT ID NCT07361679
Summary
This study is testing whether adding a daily injection of a blood thinner (low molecular weight heparin) to the standard low-dose aspirin pill works better to prevent preeclampsia in high-risk pregnant women. It will involve 100 women in Greece who are identified as high-risk early in pregnancy. The goal is to see if the two-drug combination is more effective than aspirin alone at preventing this serious condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Department of Obstetrics and Gynecology, Alexandra Hospital
RECRUITINGAthens, Attica, 11528, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.